- FraudFranklin brings deep experience in healthcare fraud and pharmacy/DEA matters, including claims under the False Claims Act, Anti-Kickback Statute, Stark Law and Controlled Substances Act. He has advised major life sciences companies in FCA cases, healthcare fraud investigations, criminal prosecutions involving FCPA and securities violations and fraud-related civil litigation.
- Money LaunderingMr. Ko advises banks and financial holding companies on all regulatory matters, including the Bank Holding Company Act, Dodd-Frank and Volcker Rule compliance and anti-money-laundering requirements and sanctions. He represents banks and their subsidiaries in front of federal and state regulatory bodies, such as the Federal Reserve, OCC, FDIC, SEC and CFTC, in regulatory and enforcement matters. He also advises broker-dealers, investment advisers and alternative investment vehicles on FINRA, NFA and other regulatory matters.
- Mergers and AcquisitionsMeisner advises on major mergers and acquisitions, merger notifications under the Hart-Scott-Rodino Act, and multinational notification regimes. He has represented clients in a variety of industries, including consumer products, defense and aerospace, automotive, high-tech, semi-conductors, building materials, hospitals, alcohol beverages, steel, mining, and aggregates.
- Intellectual PropertyMeisner defends corporations in high-stakes antitrust matters and criminal antitrust investigations. His practice focuses on complex, multi-district class action litigation alleging Sherman Act violations, U.S. Department of Justice investigations, merger investigations, and intellectual property issues. In addition, Meisner crafts global strategies for addressing cartel prosecutions and defenses, from the inception of government investigations to the initiation of civil class action and opt-out litigation in a variety of jurisdictions.
- AntitrustIn a statement accompanying the hiring announcement, the Georgetown University law school graduate said he hoped to use Steptoe & Johnson’s platform to expand his practice both on antitrust litigation and investigations, along with navigating merger clearance with enforcers.